Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 211 of 1,261
  1. US 11571498

    Drug eluting medical device

    Covidien LP · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  2. US 11572588

    Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  3. US 11571466

    Compositions and methods for treating Gaucher disease

    Takeda Pharmaceutical Company Limited · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  4. US 11571636

    Methods for quantitating individual antibodies from a mixture

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  5. US 11571484

    Compositions that target tumor-associated macrophages and methods of use therefor

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  6. US 11571485

    Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  7. US 11572359

    PARP/PI3K double-target inhibit containing pyridopyrimidine structure

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  8. US 11571444

    Enhancement of MSC immunomodulatory properties by treprostinil

    United Therapeutics Corporation · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  9. US 11571538

    Gas delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  10. US 11571428

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  11. US 11571412

    Thromboxane receptor antagonists in AERD/asthma

    Cumberland Pharmaceuticals Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  12. US 11571389

    Delivery devices and methods for making the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  13. US 11572408

    Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent

    VACCINEX, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  14. US 11572364

    Pteridinone compounds and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  15. US 11571440

    Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion

    Jazz Pharmaceuticals Ireland Limited · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  16. US 11572334

    Methods for making and using endoxifen

    ATOSSA THERAPEUTICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  17. US 11572367

    Antiviral heterocyclic compounds

    Enanta Pharmaceuticals, Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  18. US 11572591

    Methods and assays for subtyping Staphylococcus aureus clonal complex 8 strains

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  19. US 11572372

    Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds

    Medshine Discovery Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  20. US 11571431

    Aramchol salts

    GALMED RESEARCH AND DEVELOPMENT LTD · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  21. US 11572358

    Solid forms of an sGC stimulator

    Cyclerion Therapeutics, Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  22. US 11571482

    Human antibodies to S. aureus Hemolysin A toxin

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  23. US 11572377

    Nucleotide analogs

    The Regents of the University of California · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  24. US 11571446

    Gut microbiota and treatment of cancer

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.